Trials / Active Not Recruiting
Active Not RecruitingNCT06617039
The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 376 (estimated)
- Sponsor
- Northern Jiangsu People's Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To explore the impact of esketamine combined with ciprofol on the quality of early postoperative recovery in elderly patients undergoing painless gastroscopy, as well as the effectiveness and safety of this regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remifentanil and ciprofol | R group will be started with remifentanil 0.5ug/kg and ciprofol 0.4 mg/kg. |
| DRUG | esketamine 0.3mg/kg and ciprofol | Anesthesia induction was initiated by esketamine 0.3mg/kg, followed by ciprofol 0.2-0.4mg/kg. |
| DRUG | esketamine 0.5mg/kg and ciprofol | Anesthesia induction was initiated by esketamine 0.5mg/kg, followed by ciprofol 0.2-0.4mg/kg. |
| DRUG | Ciprofol | Ciprofol group will be started with ciprofol 0.2-0.4 mg/kg. |
Timeline
- Start date
- 2024-10-10
- Primary completion
- 2025-07-15
- Completion
- 2025-07-15
- First posted
- 2024-09-27
- Last updated
- 2025-05-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06617039. Inclusion in this directory is not an endorsement.